Number of transition between response states among consecutive visits
| Initial state | Subsequent state, n (row %) | Total | |
| Non-response | Response | ||
| SRI-4 | |||
| Non-response | 3735 (82.5) | 795 (17.5) | 4530 |
| Response | 395 (10.8) | 3253 (89.2) | 3648 |
| SRI-5 | |||
| Non-response | 5076 (89.0) | 629 (11.0) | 5705 |
| Response | 336 (13.6) | 2138 (86.4) | 2474 |
| SRI-6 | |||
| Non-response | 5191 (89.3) | 621 (10.7) | 5812 |
| Response | 339 (14.3) | 2028 (85.7) | 2367 |
| BICLA* | |||
| Non-response | 2392 (83.4) | 475 (16.6) | 2867 |
| Response | 287 (16.2) | 1482 (83.8) | 1769 |
*Among patients with 1A or ≥2B at baseline.
BICLA, BILAG-based Composite Lupus Assessment; SRI, SLE Responder Index.